123 related articles for article (PubMed ID: 18470760)
21. Bias and variance evaluation of QT interval correction methods.
Wang Y; Pan G; Balch A
J Biopharm Stat; 2008; 18(3):427-50. PubMed ID: 18470754
[TBL] [Abstract][Full Text] [Related]
22. Statistical consideration in testing for assay sensitivity in a "thorough" QT study.
Sethuraman V; Wu S; Wang J
J Biopharm Stat; 2010 May; 20(3):641-53. PubMed ID: 20358442
[TBL] [Abstract][Full Text] [Related]
23. Statistical characteristics of moxifloxacin-induced QTc effect.
Yan LK; Zhang J; Ng MJ; Dang Q
J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
[TBL] [Abstract][Full Text] [Related]
24. Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studies.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):615-31. PubMed ID: 20358440
[TBL] [Abstract][Full Text] [Related]
25. Man versus machine: is there an optimal method for QT measurements in thorough QT studies?
Darpo B; Agin M; Kazierad DJ; Layton G; Muirhead G; Gray P; Jorkasky DK
J Clin Pharmacol; 2006 Jun; 46(6):598-612. PubMed ID: 16707406
[TBL] [Abstract][Full Text] [Related]
26. [Predictive value of ECG changes for acute cardiac rejections in heart transplant recipients].
Tenderich G; Jahanyar J; Zittermann A; Schleithoff SS; Wlost S; Körfer R
Med Klin (Munich); 2006 Feb; 101(2):99-106. PubMed ID: 16501906
[TBL] [Abstract][Full Text] [Related]
27. Drugs, QT interval prolongation and ICH E14: the need to get it right.
Shah RR
Drug Saf; 2005; 28(2):115-25. PubMed ID: 15691222
[TBL] [Abstract][Full Text] [Related]
28. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
[TBL] [Abstract][Full Text] [Related]
29. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.
Sarapa N; Nickens DJ; Raber SR; Reynolds RR; Amantea MA
Clin Pharmacol Ther; 2008 Jan; 83(1):153-9. PubMed ID: 17581594
[TBL] [Abstract][Full Text] [Related]
30. Comparison of statistical models adjusting for baseline in the analysis of parallel-group thorough QT/QTc studies.
Sun GG; Quan H; Kringle R; Meng Z
J Biopharm Stat; 2012; 22(3):438-62. PubMed ID: 22416834
[TBL] [Abstract][Full Text] [Related]
31. Statistical characterization of QT prolongation.
Schall R; Ring A
J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
[TBL] [Abstract][Full Text] [Related]
32. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
Malik M; Hnatkova K; Batchvarov V
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
[TBL] [Abstract][Full Text] [Related]
33. Sample size and power estimation in "thorough" QT/QTc studies with parallel group design.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):578-86. PubMed ID: 20358437
[TBL] [Abstract][Full Text] [Related]
34. Prolongation of the QT-corrected interval during dobutamine stress echocardiography: a marker for ischemia.
Vora T; Pendyala P; Schünemann H; López-Candales A
Coron Artery Dis; 2003 May; 14(3):233-7. PubMed ID: 12702927
[TBL] [Abstract][Full Text] [Related]
35. Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points.
Meng Z; Kringle R; Chen X; Zhao PL
J Biopharm Stat; 2010 May; 20(3):563-77. PubMed ID: 20358436
[TBL] [Abstract][Full Text] [Related]
36. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and significance of an isolated long QT interval in elite athletes.
Basavarajaiah S; Wilson M; Whyte G; Shah A; Behr E; Sharma S
Eur Heart J; 2007 Dec; 28(23):2944-9. PubMed ID: 17947213
[TBL] [Abstract][Full Text] [Related]
38. Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability.
Malik M; Zhang J; Johannesen L; Hnatkova K; Garnett C
Heart Rhythm; 2011 Nov; 8(11):1777-85. PubMed ID: 21699874
[No Abstract] [Full Text] [Related]
39. QT analysis: a complex answer to a 'simple' problem.
Li L; Desai M; Desta Z; Flockhart D
Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
[TBL] [Abstract][Full Text] [Related]
40. Comparison of six commonly used QT correction models and their parameter estimation methods.
Wang D; Taubel J; Arezina R
J Biopharm Stat; 2012; 22(6):1148-61. PubMed ID: 23075014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
